Name change and AIM Rule 26 website
Updated : 07:01
For Release 07:00, 26 September 2024
NetScientific plc
("NetScientific" or the "Company")
Name change and AIM Rule 26 website
NetScientific Plc (AIM: NSCI), the deep tech and life sciences VC investment group, is pleased to announce that it has changed its name to "EMV Capital plc".
Regulatory information concerning the Company's name change
The Company was issued by Companies House with a change of name certificate on 25 September 2024 and the name change from "NetScientific plc" to "EMV Capital plc" became effective immediately upon such receipt. Similarly, the Company's wholly owned venture capital and corporate finance firm, EMV Capital Limited, has changed its name to EMV Capital Partners Limited with immediate effect.
The Company confirms that its change of name has been notified to the London Stock Exchange and trading in the Company's shares under the new company name and new TIDM code, "EMVC", is expected to commence at 8.00 a.m. on 26 September 2024. The Company's ISIN and SEDOL remain unchanged.
In conjunction with its name change, the Company's website address will change to emvcapital.com. All information required by Rule 26 of the AIM Rules for Companies will be located on the "Investors" section of the website with effect from 8.00 a.m. on 26 September 2024.
Shareholders rights are unaffected by these changes and existing share certificates should be retained and remain valid.
Background to the Company's name change and rebranding
The rebranding marks the culmination of NetScientific's strategic evolution, since acquiring EMV Capital in 2020, to a fully integrated venture capital and corporate finance business.
The Group has grown substantially in both scale and scope since its inception. In 2019, the Group's portfolio fair value stood at approximately £8 million. Today, through its capital-efficient model and strategic value-creation services, the Group has established itself as a key player in venture capital, spanning deep tech, life sciences, and other innovative sectors. The EMV Capital brand, used by the Group since 2020, is already highly regarded and well established in this space, and as such the name change and rebranding across the Group is a logical step towards unifying the Group's offerings to its stakeholders.
EMV Capital plc now manages a diversified portfolio of over 70 companies with estimated AUM exceeding £100 million (as announced on 13 June 2024), significantly expanding beyond its origins and is uniquely positioned to leverage its expertise across fund management, corporate finance, and portfolio growth services to deliver positive returns for investors, even when market conditions remain challenging.
As EMV Capital plc, the Group continues its expansion beyond life sciences into deep tech, including sectors such as sustainability, digital health, and advanced materials. The Company's ability to provide fund management, corporate finance, and syndication services across its portfolio enables it to identify, nurture, and accelerate the growth of early-stage companies. By offering hands-on support through each growth phase, EMV Capital is committed to helping companies scale while delivering meaningful societal impact.
With a goal to further grow Assets Under Management, the Group aims to scale its capital-efficient investment model, expand its fund management practice, and enhance the value of its portfolio through targeted investments and value-creation services.
Dr. Ilian Iliev, CEO of EMV Capital plc, commented:
"Since acquiring EMV Capital in 2020, we have consolidated our operations, significantly grown our portfolio, and expanded our strategic focus. This new identity for our Group reflects our business today-an agile, multi-sector venture capital firm committed to delivering superior returns from innovative, high-growth companies.
"With Assets Under Management having surpassed £100 million, this milestone highlights our success in navigating a challenging market and underscores our ambitious plans for the future. Our continued focus on deep tech and life sciences, combined with our value-creation approach, positions EMV Capital to be at the forefront of driving the next wave of innovation and shareholder value."
-Ends-
For more information, please contact: | |
EMV Capital plc | via Rosewood |
Ilian Iliev, CEO |
|
|
|
Panmure Liberum (UK) Limited (NOMAD and Broker) | +44 (0)20 7886 2500 |
Emma Earl / Will Goode / Freddy Crossley / Mark Rogers (Corporate Finance) |
|
Rupert Dearden (Corporate Broking) |
|
|
|
Rosewood (Financial PR) | +44 (0)20 7653 8702 |
John West / Llewellyn Angus / Lily Pearce |
|
About EMV Capital plc (EMVC)
EMV Capital plc, formerly known as NetScientific plc, is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies.
With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future; EMV Capital invests in, manages and strengthens early stage IP-rich companies.
EMV Capital holds both direct equity stakes and carried interest in its portfolio companies, creating an evergreen structure that supports extensive growth and value creation. EMV Capital's investment thesis is realised through these capital sources:
· capital-efficient investments through Group balance sheet;
· fund management of the Evergreen EIS and Martlet Capital Funds;
· syndicated investments leveraging its network of third-party investors.
EMV Capital's approach is characterised by its proactive management style, aiming to advance portfolio companies to critical value inflection points by actively engaging with them. Companies are supported through Board representation and the use of its Value Creation Services practice.
Headquartered in London, with a Cambridge presence and strong international links, EMV Capital is quoted on the AIM market of the London Stock Exchange.
For more information, visit www.emvcapital.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.